Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
3 Biotech|April 10, 2017
Isolation, identification, and environmental adaptability of heavy-metal-resistant bacteria from ramie rhizosphere soil around mine refineryJie Jiang, Chaohu Pan, Aiping Xiao, et al.
Frontiers in Cell and Developmental Biology|March 4, 2022
Expression Patterns of Glycosylation Regulators Define Tumor Microenvironment and Immunotherapy in Gastric CancerFang Li, Kaibin Huang, Chaohu Pan, et al.
Frontiers in Oncology|February 3, 2023
An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanomaChaohu Pan, Hongzhen Tang, Wei Wang, et al.
The Journal of General Virology|August 29, 2025
Mechanistic insights into Nipah virus 5' UTR functionality reveal an antiviral targetLishi Liu, Chaohu Pan, Zhen Chen, et al.
Frontiers in Oncology|November 25, 2022
Systematic assessment and optimizing algorithm of tumor mutational burden calculation and their implications in clinical decision-makingDaqiang Sun, Meilin Xu, Chaohu Pan, et al.
The Journal of Infectious Diseases|September 20, 2025
Mycobacterium tuberculosis PE_PGRS62 Protein Inhibits Type I Interferon Responses to Promote HIV-2 Replication by Directly Interacting With Interferon Regulatory Factor 3Chaohu Pan, Hui Xu, Min Huang, et al.
Frontiers in Genetics|February 14, 2022
The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung AdenocarcinomaWan He, Gengpeng Lin, Chaohu Pan, et al.
Frontiers in Genetics|April 1, 2022
Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung AdenocarcinomaWan He, Gengpeng Lin, Chaohu Pan, et al.
Frontiers in Immunology|June 25, 2025
CDK2 inhibition sensitizes anthracycline-induced immunogenic cell death and enhances the efficacy of anti-PD-1 therapyYu Chen, Wancheng Liu, Qiaomei Cai, et al.
Anti-Cancer Drugs|August 10, 2022
Unexpected favorable outcome to sintilimab monotherapy in a relapse pancreatic ductal adenocarcinoma patient with high tumor mutational burden: a case reportFan Zhang, Xiaomin Li, Haisheng Liu, et al.
Pageof 3